HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Revision hip arthroplasty using a modular revision hip system in cases of severe bone loss.

Abstract
We sought to identify outcomes of the Restoration Modular Hip System in cases of severe femoral bone stock deficiency. We performed a retrospective review of 55 revTHAs with a mean follow-up of 32 months (24-60 months). Outcomes included the WOMAC and HHS. Preoperative bone loss was categorized as Paprosky 3A (n = 13), 3B (n = 14), and 4 (n = 17). Periprosthetic fractures were classified as Vancouver B2 (n = 6) and B3 (n = 5). 53 of 55 stems were in situ at time of final review. WOMAC improved from 46 ± 18 to 70 ± 22 and HHS improved from 47 ± 15 to 78 ± 15. Complications were identified in 9 patients, which included dislocation (3), subsidence (2), infection (2), and periprosthetic fracture (2). In cases of significant proximal femoral bone deficiency, this stem demonstrated improvement in clinical outcomes with good results at short-term follow up.
AuthorsIvan Dzaja, Matt C Lyons, Richard W McCalden, Douglas D D Naudie, James L Howard
JournalThe Journal of arthroplasty (J Arthroplasty) Vol. 29 Issue 8 Pg. 1594-7 (Aug 2014) ISSN: 1532-8406 [Electronic] United States
PMID24768500 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Topics
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip (adverse effects, methods)
  • Databases, Factual
  • Disability Evaluation
  • Female
  • Femur (diagnostic imaging, surgery)
  • Follow-Up Studies
  • Hip Dislocation (diagnostic imaging, etiology, surgery)
  • Hip Prosthesis (adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Pain Measurement (methods)
  • Periprosthetic Fractures (diagnostic imaging, etiology, surgery)
  • Prosthesis Design
  • Prosthesis Failure
  • Radiography
  • Reoperation (methods)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: